Atlas Trials

Study of ARO-AAT in Normal Adult Volunteers

Clinical trial NCT03362242 · COMPLETED

Trial details

NCT number
NCT03362242
Sponsor
Arrowhead Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alpha 1-Antitrypsin Deficiency
Start date
2018-03-12
Primary completion
2018-10-23
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.